-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Downgrades Vistagen Therapeutics to Hold

Benzinga·12/17/2025 20:46:24
Listen to the news
Maxim Group analyst Jason McCarthy downgrades Vistagen Therapeutics (NASDAQ:VTGN) from Buy to Hold.